These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30462746)

  • 1. The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder.
    Takahashi S; Ohmiya M; Honda S; Ni K
    PLoS One; 2018; 13(11):e0207750. PubMed ID: 30462746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3.
    Takahashi S; Inamura K; Yarimizu J; Yamazaki M; Murai N; Ni K
    Eur J Pharmacol; 2017 Sep; 810():26-35. PubMed ID: 28552344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASP2905, a specific inhibitor of the potassium channel Kv12.2 encoded by the Kcnh3 gene, is psychoactive in mice.
    Takahashi S; Okamura A; Yamazaki M; Ni K
    Behav Brain Res; 2020 Jan; 378():112315. PubMed ID: 31654662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
    Kawaura K; Karasawa J; Chaki S; Hikichi H
    Behav Brain